Bioxcel Therapeutics Inc (BTAI) Annual Balance Sheets

Annual · GAAP · USD millions
Access BTAI quarterly Balance Sheets →
Balance sheet performance over multiple periods helps investors evaluate the financial resilience of Bioxcel Therapeutics Inc.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent28.42
Cash & Short-term Investments28.00
Accounts receivable0.23
Inventories0.72
Other Current Assets11.29
Prepaid Expense And Other Assets Current4.03
Total Current Assets44.69
Equipment/Property/Plant Net0.18
Other Assets, Noncurrent0.00
Restricted Cash Current0.34
Operating Lease Right Of Use Asset0.06
Total Assets44.92
Liabilities
Accounts Payable, Current AC14.70
Accrued Liabilities, Current AC4.34
Long-term Debt, Current Maturities LO24.93
Other Liabilities, Current9.95
Total Current Liabilities53.93
Long-term debt84.66
Total Long-term Debt84.66
Derivative Liability, Noncurrent DE1.79
Other liabilities, Noncurrent0.00
OperatingLeaseLiabilityNoncurrent-
Total Liabilities140.38
Stockholders' Equity
Common Stock Value0.08
Additional Paid In Capital Common Stock624.56
Retained Earnings / Accumulated Deficit-720.09
Other Equity0.00
Common Stockholder's Equity-95.46
Total Stockholder's Equity-95.46
Liabilities & Stockholder's Equity44.92
4 historic quarters locked

Sign in to unlock the full Bioxcel Therapeutics Inc balance sheet history.

About Bioxcel Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-036214

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License